Epilepsia Open® Prize 2022 Basic Science

Morgan Sturgeon

Morgan Sturgeon (United States) was awarded the Epilepsia Open prize for her research, The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.

Sturgeon ML, Langton R, Sharma S, Cornell RA, Glykys J, Bassuk AG. The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models. Epilepsia Open. 2021;6(3):528-538. doi:10.1002/epi4.12512

An interview with Morgan Sturgeon, 2022 Epilepsia Open prize winner for basic science research